chrisvoncsefalvay/vaers-outcomes huggingface dataset:
GRIP STRENGTH DECREASED/CANT GRAB THINGS; COVID-19; PAINFUL HAND; This spontaneous report received from a patient concerned an adult female. The patient's height, and weight were not reported. The patient's concurrent conditions included: moderate to severe rheumatoid arthritis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) dose was not reported, administered on 2021 for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Non-company suspect drugs included: upadacitinib (form of admin unknown, oral, batch number was not reported) dose, frequency, and therapy dates were not reported for moderate to severe rheumatoid arthritis. Age at time of vaccination 6 decade old. No concomitant medications were reported. On an unspecified date, the patient experienced grip strength decreased/cant grab things, covid-19, and painful hand. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and dose of upadacitinib was not changed. The outcome of the painful hand, grip strength decreased/cant grab things and covid-19 was not reported. This report was non-serious.
itchy rash; Red rash inside left elbow/Red itchy rash would appear intermittently inside left elbow.; This is a spontaneous report from a non-contactable consumer (patient). A 23-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EW0161), via an unspecified route of administration, administered in left arm on 20Apr2021 (at the age of 23-year-old) as dose 2, single, and received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: ER8730), via an unspecified route of administration, administered in left arm on an unspecified date in Mar2021 (at the age of 23-year-old) as dose 1, single for covid-19 immunization in a Pharmacy or Drug Store. The patient was not pregnant at the time of vaccination. The patient medical history included congenital heart disease and 22Q deletion variant. The patient's concomitant medication included daily vitamins. The patient had not received any other vaccine within 4 weeks prior to vaccination. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 31Mar2021, the patient had experienced red rash inside left elbow and on 21Apr2021, the patient had red itchy rash which appeared intermittently inside left elbow. The patient had not received any treatment for the events. The outcome of events was recovered at the time of report.  No follow-up attempts are possible. No further information is expected.
A couple days after receiving the vaccine I broke out in what I can only describe as hives or shingles. I had extreme pain and itching  mostly on my legs, but also on my shoulders, shoulder blades and sides  of my torso. The bumps on my legs got really big and began oozing.  My legs still have a bit of soreness.none
Administered vaccine that was stored at temperature between -80 degree Fahrenheit to -84 degree Fahrenheit; Administered vaccine that was stored at temperature between -80 degree Fahrenheit to -84 degree Fahrenheit; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree Fahrenheit to -84 degree Fahrenheit) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree Fahrenheit to -84 degree Fahrenheit) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021 at 6:08 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Nov-2021 at 6:08 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree Fahrenheit to -84 degree Fahrenheit). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree Fahrenheit to -84 degree Fahrenheit). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree Fahrenheit to -84 degree Fahrenheit) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree Fahrenheit to -84 degree Fahrenheit) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided.  It was reported that the vaccine was at frozen storage condition at the time of the temperature excursion. Excursion duration was 1 month.  On 19-Nov-2021, the Moderna COVID-19 vaccine vial went from the super cold freezer to the refrigerator. The vaccine was returned to the freezer/refrigerator/ultra cold freezer, or maintained at room temperature.  No vaccine state changes were noticed. The vaccine was never refrozen. None of the vials were punctured. No previous temperature excursion issues had happened.  The patient was given doses from a vial that were stored in an ultracold freezer which is colder than they should have been.   This case was linked to MOD-2021-402935 (Patient Link).
COVID like symptoms; Not Hungry; Hardly Moved; High Temperature <100 F; Joint Pain; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID like symptoms), DECREASED APPETITE (Not Hungry), MOBILITY DECREASED (Hardly Moved), PYREXIA (High Temperature <100 F) and ARTHRALGIA (Joint Pain) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced COVID-19 (COVID like symptoms), DECREASED APPETITE (Not Hungry), MOBILITY DECREASED (Hardly Moved), PYREXIA (High Temperature <100 F), ARTHRALGIA (Joint Pain), HEADACHE (Headache) and CHILLS (Chills). On 08-Mar-2021, COVID-19 (COVID like symptoms), DECREASED APPETITE (Not Hungry), MOBILITY DECREASED (Hardly Moved), PYREXIA (High Temperature <100 F), ARTHRALGIA (Joint Pain), HEADACHE (Headache) and CHILLS (Chills) had resolved.            No relevant concomitant medications were reported. No treatment information was provided.  Action taken with the mRNA-1273 in response to the event is not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: TCR received on 03-May-2021 and does not contain any new information, denied further follow up
therapy non-responder; This case was reported by a consumer via call center representative and described the occurrence of therapy non-responder in a 77-year-old male patient who received HAV (Havrix adult) (batch number 37RY4, expiry date 6th March 2021) for prophylaxis.   On 17th June 2019, the patient received Havrix adult. In July 2019, less than 3 weeks after receiving Havrix adult, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown.   It was unknown if the reporter considered the therapy non-responder to be related to Havrix adult.  Additional details were provided as follows: The patient received a dose of Havrix in the right arm had his blood work done about 2 and a half weeks later and it was negative for hepatitis A antibodies. The physician recommended to get revaccinated after 7th September 2019. The patient consented to follow up.      Lab Comments: On an unknown date lab test was performed
Received Tdap on 11 December. On 16-17 December she felt unwell, complaining of nausea, then vomiting, and headache. Presented to ER on Monday 18 December and was sent home with work excuse for 3 days, but re-presented 19 December. She was brought by her husband with mental status changes, confusion with expressive aphasia and husband reported she had headache, neck pain and stiffness. LP revealed findings c/w encephalitis vs viral meningitis and she was admitted, treated with acyclovir, dexamethasone and antibiotics. Her mental status waxed and waned on the first two days. She had a seizure on 20 December, treated with dilantin, and was very encephalopathic requiring 1 on 1 nursing observation and support for confusion. On 21 December her symptoms improved and she was discharged on 22 December with no apparent confusion, although her memory is poor for all events from 16 - 23 December. She did not return to work for another several days.  1/23/07 Received medical records from hospital which reveal patient admitted 12/19-12/22/06 for acute mental status changes of confusion, naming difficulties, expressive aphasia, HA, stiff neck, photophobia & 2 days of nausea. Received flu vax 12/1, TDaP on 12/11 & PPD on 12/11.  LP done. Neuro, ID consults done. Treated with antibiotics & antivirals, steroids.  Mental status waxed & waned & then she had a seizure & remained confused & nonverbal for several hours afterward.  Treated w/Dilantin.  Stabilized, mental status cleared & was d/c to home to f/u w/PCP, ID & Neuro. FINAL DX: Meningitis/encephalitis w/seizrues.  ID consult felt dx due to vax & timing favored DTap over flu.
10:00am done with shot, 1/2 hour observation, 10 to 15 minutes later driving home felt need to have a BM, arriving home had diarrhea then tremors of both hands, fast heart, and extreme tiredness
I received my 2nd Covid 19 shot at clinic. I began to get sick that night. But by 4:00 am I woke up with seizures, freezing cold, nausea, fatigue, fever of 101.3, pain throughout my body. I had slightly labored breathing and took Elderberry juice. My nose was stuffy. I have a slight wheezy cough. Slightly labored breathing, not severe. I took ibuprofen 500 mg yesterday for the sore shoulder.  This morning at I took Bayer's low-dose chewable tablets 350 mg. I really couldn't eat much from nausea, but I ate applesauce, broth, juices, and water. Later that day, as suggested by my doctor I took Tylenol PM. I am feeling 50% better the next day. High 102.5 Temperature went away in 48 hours.
pt recv multiple vax p/a complete unremarkable well baby visit;observed in clinic for 30min;given APAP prophylactically;discovered the following day dead;autopsy completed COD: unexplained death of infancy SIDS;
Information has been received from a physician concerning a patient (age and sex not reported) who on an unspecified date was vaccinated with Rotateq (unknown how many doses of the vaccine the patient received). On 24-APR-2007, the patient experienced intussusception and was admitted to the hospital. The patient had surgery to remedy the situation. The reporter felt that intussusception was not related to therapy with Rotateq. Intussusception was considered to be immediately life-threatening and other important medical event. No further information was available from physician.
Swollen Lymph nodes under Rt arm for 3 days   This is day 7 and all is resolved.
Pt recvd 2 doses of Engerix-B & a few hrs p/2nd dose 3MAR92 devel difficulty breathing & hives;
Large localized reaction in arm at site of both vaccines, profound lethargy, chills and bone aches in a strong healthy male.
Severe diarrhea, body ache, head ache, fever (99.5) for 24 hours. Pushed liquids and stayed in bed.  Previous flu shots resulted in no reactions.
Severe pain, warmth @ injection site (R deltoid), 2x2cm painful palpable R axillary lymph node, fever to 100.4, inability to lift R arm, extreme fatigue, chills, muscle aches.  Treated with around the clock antiinflammatories and fever reducing meds, heat application.
Information has been received from a physician concerning a female who was vaccinated with a dose of GARDASIL (Lot# unknown). Subsequently the patient experienced weight gain. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Tdap given on 06-11-09.  Began having an elevated temperature on 06-12-09.  Also c/o headache, stomach ache, + diarrhea.  Highest temperature was 101.9.  Afebrile on 06-15-09, Headache gone.  Still some diarrhea.
Information has been received from a nurse practitioner concerning a 23 year old white male with no medical history or allergies who on 19-OCT-2006 at 14:30 was vaccinated in the right arm with a SC 0.5 mL dose of MMR (lot # 653338/0216F). Vaccination history was not available. There patient was illness at the time of vaccination. Vaccination history not available. On 31-OCT-2006 the patient reported developing a low fever(>100), muscle aches, and a red rash on his shoulders. It was also reported that the morning of 31-OCT-2006 the patient developed lymphadenopathy, post-cervical and post-auricular. He also developed a generalized maculo-papular rash over his face with a few patches on his chest and upper back. Unspecified medical attention was sought. A CBC was performed that indicated slightly low levels of white blood cells(3.3) and eosinophils(13). All other values were normal. The patient recovered. The patient did not experience any adverse events following prior vaccinations. There was no product quality complaint involved. Additional information is not expected.
pt recv vax 13OCT97 about 1wk later lt deltoid started aching;also has arthritis which causes aching;no redness, warmness, or hardness noted when came into have it checked;
Breakthrough case admission after 3 vaccines Moderna 4/20/21 Lot# 044B21A;  Moderna 5/22/21 Lot# 50C21A; MOderna 12/1/21 Lot# 058H21A
Upper GI hemorrhage s/p EGD with clipping and hemostasis of actively bleeding duodenal ulcer. She was monitored closely after the endoscopy and on HD 2 had a further 2g drop in hemoglobin. Finally in the morning on hospital day 3, her hemoglobin demonstrated stability and she had no further melena.  She was thus deemed stable to discharge home. ED visit and hospital admission within 6 weeks of receiving the COVD Vaccine.
Aches, pain, fever for 52 hours after shot. Chills missed a week of work.Dr .
Five minutes after vaccination experiencing nausea racing heart and feelings of passing out was taken over to the ER where I was hooked up to monitor to monitor my heart and EKG and lab work I was there for three hours until my heart calmed down still experiencing some chest pain and mild discomfort and tachycardia even after being discharged from the ER
Pt recv vax on 9/4/98; five minutes later pt exp seizure-like tremors lasting one min.  Pt recovered well with out problems.
patient had redness, swelling, and pain develop over a large area where the immunization was given. The area was about 3-4 inches across when I saw it. She had seen a physician, who diagnosised it  as possible cellulitis, per the patient. She was given antibiotics, cephalexin, to treat this.
Narrative: 86 year old male admitted on August 6 2022 with from CLC COVID-19 infection with fever. He had received Moderna x 4 on December 28 2020, January 27 2021, October 29 2021, June 9 2022. He was treated with remdesivir 200 mg x 1 then 100 mg daily x 4 days and dexamethasone 6 mg IV daily x 5 days.. He improved on treatment and was discharged from acute medicine floor on 8/11/2022.
The day after vaccination I lost vision for an hour then had onset migraine. Migraines continued and then had sudden onset of vertigo, ataxia, nausea, and vomiting  6 days following vaccine.  I could not walk with the ataxia for several days and ended up in ED  8 days after vaccine for persistent vertigo, migraines, and nausea not improved with antivert and imitrex. I do have a history of migraines but I have never experienced this vertigo and migraines lasting days on end. I am now currently 19 days past vaccine and still with vertigo and migraines.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 27-SEP-2013, the patient were vaccinated with a dose of ZOSTAVAX (lot# J001694, expiration date 08-MAY-2014, dose, frequency, route and indication not reported). The vaccine was stored improperly at temperatures up to 21F from 01-JUL-2013 to 08-OCT-2013. On 08-OCT-2013, the vaccine was discarded. No adverse effects were reported. It was unspecified if the patient had sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
This medically confirmed report (initial receipt: 25-Mar-2013) concerns a 64-year old male patient who had a medical history of drug reaction/allergy to shellfish and elevated homocysteine. On 22-Oct-2012, the patient received AFLURIA (batch number: P51208) intramuscularly in the left deltoid. On 05-Feb-2013, the patient had an office visit and complained of arm pain. He had intermittent sensation in the left arm. The discomfort was very severe when swimming and limited the patient's activities. He had weakness, pain and reduced range of motion. There was no tingling and no numbness. On 18-Feb-2013 the patient had a magnetic resonance imaging (MRI) of the brachial plexus. The patient's physician and radiologist were reviewing the MRI results which were not available at time of reporting. Follow-up lab work included chem panel, hemoglobin, A1C, thyroid stimulating hormone (TSH) and white blood count (WBC), results were not provided. On 20-Mar-2013, the patient returned to the office with progressive left arm and shoulder pain and loss of motion. No further information was available.
I noticed inflammation around my right shoulder blade and it was painful to sleep on right side or my back. I noticed my right collar bone had some slightly inflammation around lymph nodes which has last for a little over a month now.  I'm continuing to monitor. A few days after the vaccine, my teeth were sensitive and hurt when i tried to brush them. I also noticed my tongue was a little bigger than usual. I took Tylenol and about 3-4 days after the vaccine the teeth sensitivity and the swelling in tongue went down. However, recently I went to the dentist (about 3 weeks after the 2nd dose) and I noticed my jaw locking a bit (which has not happened during my cleanings before). The slight inflammation around my right collar bone still exists, so I'm continuing to monitor it.
This spontaneous report was received from a healthcare worker refers to unspecified number of patients of unknown gender and age. Information regarding patients' medical history, concurrent condition, drug reactions/allergies and concomitant therapy were not provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 (lot # L019297, expiry date: 18-AUG-2017 and lot # L043213, expiry date: 28-AUG-2017). Healthcare worker reported that the vaccine underwent temperature excursion at 34 degree Fahrenheit for 72 hours. There were no previous excursions. No adverse effects were reported. This is one of the three reports received from the same reporter. Additional information has been requested.
Pt reported feeling like she was going to pass out at around 10pm on 1/26/21 and lowered herself to the floor in her bathroom.  Was discovered on the floor around noon, 14 hours later,  by staff after noticing  her food tray was untouched . Arrived in ED via EMS. Pt was febrile with rectal temp 100.7 c/o weakness. Pt  had a WBC  count of 11.2, absolute neutrophil  9.9, and creatine kinase 3214.  Pt was alert and oriented  and reported  having been hospitalized for a few weeks in November 2020 with Covid-19 and having received her first dose of covid vaccine at approximately 11:30 on 1/26/21. Hospitalist voiced concerns that this may be a reaction to  covid vaccination.
approx. 10 min after infection my heart started pounding in my chest, felt dizzy and weak. Was monitor for 45 min, blood pressure was  stable , heart rate 120s. Was taken to ER, took 2 person assist to transfer to cart because I felt very weak, like I was going to pass out. In ER was given liter of fluid, Benadryl 25mg ivp. After about 45 min my symptoms started improving. By 90 mins later I was able to walk out of the ER
Fever; Body aches; Headache; Arm soreness; This case was reported by a consumer and described the occurrence of fever in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had experienced shingles 3 times, beginning when was 11).   On 4th January 2023, the patient received Shingrix. On 4th January 2023, less than a day after receiving Shingrix, the patient experienced fever, general body pain, headache and pain in arm. On an unknown date, the outcome of the fever, general body pain, headache and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the fever, general body pain, headache and pain in arm to be related to Shingrix.     Additional Information: GSK Receipt date: 05-Jan-2023. Reporter's Comment: This report was submitted via the online direct entry reporting system. The symptoms were treated. The reporter consented to follow up.
Positive PCR 1/12/22, positive again 1/25/22. Inpatient 1/16-17, found to have L sided otitis media.
felt sick for a few hours after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt sick for a few hours after 1st dose) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     Concomitant products included Zoloft                                                         anti-anxiety/antidepressant for Antidepressant discontinuation syndrome, Metoprolol                                                     blood pressure medication for Blood pressure.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced MALAISE (felt sick for a few hours after 1st dose). At the time of the report, MALAISE (felt sick for a few hours after 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-110610 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-110610:
patient came back saturday after receiving a flu and pneumovax shot on thursday night. she complained of pain, redness, swelling and she calims she had a fever as well. Told her to try some benadryl tonight and if that doesnt help the redness and swelling then to go see the doctor tomorrow. Tylenol for fever if it is present.